INFIRMARY LTAC HOSPITAL
1. Target Overview & Investment Thesis
INFIRMARY LTAC HOSPITAL is a 31-bed community hospital in MOBILE, AL with $10.5M in net patient revenue and a -11.9% operating margin. The hospital serves a payer mix of 61.0% Medicare, 0.0% Medicaid, and 39.0% commercial.
Thesis: Turnaround. Our ML models identify $776K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -11.9% to -4.5% (+741bps).
| Net Revenue HCRIS | $10.5M |
| Current EBITDA COMPUTED | $-1.2M |
| Operating Margin COMPUTED | -11.9% |
| Occupancy HCRIS | 62.5% |
| Revenue / Bed COMPUTED | $338K |
| Net-to-Gross HCRIS | 38.5% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -11.9% places it below the state median. Among 54 size-comparable peers (16-62 beds), the median margin is -16.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (16-62), prioritizing same-state peers. 54 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| INFIRMARY LTAC HOSPITAL (Target) | AL | 31 | $10.5M | -11.9% |
| RUSSELL MEDICAL CENTER | AL | 45 | $75.3M | -14.8% |
| JACK HUGHSTON MEMORIAL HOSPITA | AL | 47 | $75.2M | 6.5% |
| NORTH BALDWIN INFIRMARY | AL | 35 | $55.3M | -3.3% |
| PRATTVILLE BAPTIST HOSPITAL | AL | 55 | $53.5M | -16.2% |
| HIGHLANDS MEDICAL CENTER | AL | 45 | $45.9M | -30.2% |
| ST. VINCENTS ST. CLAIR | AL | 40 | $40.8M | 8.7% |
| TROY REGIONAL MEDICAL CENTER | AL | 41 | $39.0M | -9.1% |
| WHITFIELD REGIONAL HOSPITAL | AL | 47 | $38.7M | -21.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $776K (741bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $220K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $210K | +200bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $209K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $127K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +9bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-1.2M |
| + RCM Uplift | +$776K |
| Pro Forma EBITDA | $-470K |
| Current Margin | -11.9% |
| Pro Forma Margin | -4.5% |
| WC Released (1x) | $402K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-1.9M | $-456K | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-1.9M | $-1.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-1.7M | $816K | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-1.7M | $381K | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-2.1M | $-3.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-2.1M | $-4.8M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 61.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 54 hospitals with 16-62 beds
- Same-state prioritization (n=55)
- Comp margins: P25=-28.5% / P50=-16.2% / P75=-2.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.